Assertio Holdings, Inc. (ASRT)
USD 0.61
(-1.4%)
USD 0.61
(-1.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -243.53 Million USD | -56.86% |
| 2022 | 57.81 Million USD | 513.48% |
| 2021 | 9.42 Million USD | 120.09% |
| 2020 | -46.91 Million USD | -1565.7% |
| 2019 | 3.2 Million USD | -92.67% |
| 2018 | 43.65 Million USD | 203.51% |
| 2017 | -42.18 Million USD | -272.1% |
| 2016 | 24.5 Million USD | 148.63% |
| 2015 | -50.4 Million USD | -121.28% |
| 2014 | 236.81 Million USD | 2441.74% |
| 2013 | 9.31 Million USD | 130.7% |
| 2012 | -30.35 Million USD | -142.93% |
| 2011 | 70.69 Million USD | 1850.29% |
| 2010 | 3.62 Million USD | 116.42% |
| 2009 | -22.07 Million USD | -29.11% |
| 2008 | -17.09 Million USD | -135.96% |
| 2007 | 47.53 Million USD | 214.25% |
| 2006 | -41.6 Million USD | -56.94% |
| 2005 | -26.51 Million USD | -0.67% |
| 2004 | -26.33 Million USD | 10.42% |
| 2003 | -29.39 Million USD | -3.42% |
| 2002 | -28.42 Million USD | -98.5% |
| 2001 | -14.32 Million USD | -85.07% |
| 2000 | -7.73 Million USD | -40.94% |
| 1999 | -5.49 Million USD | -66.38% |
| 1998 | -3.3 Million USD | -153.85% |
| 1997 | -1.3 Million USD | -160.0% |
| 1996 | -500 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.61 Million USD | 41.01% |
| 2024 Q2 | -1.71 Million USD | 0.0% |
| 2023 FY | 24.94 Million USD | -56.86% |
| 2023 Q2 | 12.42 Million USD | -15.01% |
| 2023 Q3 | -228.27 Million USD | -1937.93% |
| 2023 Q4 | -6.13 Million USD | 97.31% |
| 2023 Q1 | 14.61 Million USD | -32.75% |
| 2022 FY | 57.81 Million USD | 513.48% |
| 2022 Q4 | 21.73 Million USD | 111.88% |
| 2022 Q1 | 11.55 Million USD | 44.81% |
| 2022 Q2 | 10.79 Million USD | -6.64% |
| 2022 Q3 | 10.25 Million USD | -4.96% |
| 2021 Q2 | -12 Million USD | -259.86% |
| 2021 Q3 | 5.93 Million USD | 149.45% |
| 2021 Q4 | 7.98 Million USD | 34.51% |
| 2021 FY | 9.42 Million USD | 120.09% |
| 2021 Q1 | 7.5 Million USD | 122.68% |
| 2020 Q2 | -25.75 Million USD | -54.83% |
| 2020 Q3 | -4.81 Million USD | 81.31% |
| 2020 FY | -46.91 Million USD | -1565.7% |
| 2020 Q1 | -16.63 Million USD | 91.29% |
| 2020 Q4 | -33.09 Million USD | -587.49% |
| 2019 Q4 | -190.98 Million USD | -1784.78% |
| 2019 Q2 | 3.61 Million USD | 17.77% |
| 2019 Q3 | -10.13 Million USD | -380.07% |
| 2019 FY | 3.2 Million USD | -92.67% |
| 2019 Q1 | 3.07 Million USD | 123.48% |
| 2018 Q3 | 9.62 Million USD | 327.88% |
| 2018 FY | 43.65 Million USD | 203.51% |
| 2018 Q1 | 51.33 Million USD | 257.07% |
| 2018 Q2 | -4.22 Million USD | -108.23% |
| 2018 Q4 | -13.08 Million USD | -235.87% |
| 2017 Q4 | -32.68 Million USD | -2740.15% |
| 2017 FY | -42.18 Million USD | -272.1% |
| 2017 Q1 | -6.66 Million USD | -137.23% |
| 2017 Q2 | -4.06 Million USD | 38.96% |
| 2017 Q3 | 1.23 Million USD | 130.43% |
| 2016 FY | 24.5 Million USD | 148.63% |
| 2016 Q4 | 17.9 Million USD | 1323.21% |
| 2016 Q3 | 1.25 Million USD | -86.98% |
| 2016 Q2 | 9.66 Million USD | 323.95% |
| 2016 Q1 | -4.31 Million USD | 83.76% |
| 2015 Q2 | -17.21 Million USD | -74.78% |
| 2015 Q1 | -9.84 Million USD | -106.24% |
| 2015 Q3 | 3.23 Million USD | 118.79% |
| 2015 Q4 | -26.57 Million USD | -921.39% |
| 2015 FY | -50.4 Million USD | -121.28% |
| 2014 FY | 236.81 Million USD | 2441.74% |
| 2014 Q4 | 157.82 Million USD | 845.04% |
| 2014 Q3 | 16.7 Million USD | -37.09% |
| 2014 Q2 | 26.54 Million USD | -25.74% |
| 2014 Q1 | 35.74 Million USD | 377.86% |
| 2013 FY | 9.31 Million USD | 130.7% |
| 2013 Q1 | -5.53 Million USD | -42.2% |
| 2013 Q3 | 6.83 Million USD | 1185.34% |
| 2013 Q2 | 532 Thousand USD | 109.62% |
| 2013 Q4 | 7.48 Million USD | 9.39% |
| 2012 Q3 | -1.54 Million USD | 90.36% |
| 2012 Q1 | -8.93 Million USD | 30.21% |
| 2012 FY | -30.35 Million USD | -142.93% |
| 2012 Q4 | -3.89 Million USD | -152.5% |
| 2012 Q2 | -15.98 Million USD | -78.82% |
| 2011 Q1 | 98.8 Million USD | 8045.84% |
| 2011 Q2 | -5.99 Million USD | -106.07% |
| 2011 Q4 | -12.8 Million USD | -37.56% |
| 2011 FY | 70.69 Million USD | 1850.29% |
| 2011 Q3 | -9.31 Million USD | -55.27% |
| 2010 Q3 | 1.92 Million USD | -54.54% |
| 2010 Q1 | -3.73 Million USD | -0.59% |
| 2010 Q2 | 4.22 Million USD | 213.14% |
| 2010 Q4 | 1.21 Million USD | -36.89% |
| 2010 FY | 3.62 Million USD | 116.42% |
| 2009 FY | -22.07 Million USD | -29.11% |
| 2009 Q1 | -10.18 Million USD | 10.75% |
| 2009 Q2 | -9.59 Million USD | 5.82% |
| 2009 Q3 | 1.41 Million USD | 114.77% |
| 2009 Q4 | -3.71 Million USD | -362.36% |
| 2008 Q4 | -11.4 Million USD | -2040.53% |
| 2008 Q3 | -533 Thousand USD | -118.18% |
| 2008 Q2 | 2.93 Million USD | 136.27% |
| 2008 Q1 | -8.08 Million USD | -133.27% |
| 2008 FY | -17.09 Million USD | -135.96% |
| 2007 Q4 | 24.29 Million USD | -44.69% |
| 2007 Q1 | -11.27 Million USD | -17.07% |
| 2007 FY | 47.53 Million USD | 214.25% |
| 2007 Q2 | -9.41 Million USD | 16.52% |
| 2007 Q3 | 43.92 Million USD | 566.68% |
| 2006 FY | -41.6 Million USD | -56.94% |
| 2006 Q3 | -13.12 Million USD | -24.96% |
| 2006 Q2 | -10.5 Million USD | -25.83% |
| 2006 Q1 | -8.34 Million USD | -83.58% |
| 2006 Q4 | -9.63 Million USD | 26.62% |
| 2005 FY | -26.51 Million USD | -0.67% |
| 2005 Q1 | -6.71 Million USD | -17.54% |
| 2005 Q2 | -7.84 Million USD | -16.79% |
| 2005 Q3 | -7.4 Million USD | 5.52% |
| 2005 Q4 | -4.54 Million USD | 38.63% |
| 2004 Q4 | -5.71 Million USD | 11.91% |
| 2004 Q1 | -6.6 Million USD | 29.62% |
| 2004 FY | -26.33 Million USD | 10.42% |
| 2004 Q2 | -7.53 Million USD | -14.2% |
| 2004 Q3 | -6.48 Million USD | 13.97% |
| 2003 Q3 | -6.85 Million USD | 2.28% |
| 2003 Q4 | -9.37 Million USD | -36.79% |
| 2003 Q2 | -7.01 Million USD | -14.11% |
| 2003 Q1 | -6.14 Million USD | 37.86% |
| 2003 FY | -29.39 Million USD | -3.42% |
| 2002 Q4 | -9.89 Million USD | -19.51% |
| 2002 FY | -28.42 Million USD | -98.5% |
| 2002 Q3 | -8.27 Million USD | -46.31% |
| 2002 Q2 | -5.65 Million USD | -23.12% |
| 2002 Q1 | -4.59 Million USD | -16.3% |
| 2001 Q3 | -3.76 Million USD | 6.11% |
| 2001 Q1 | -2.6 Million USD | 7.92% |
| 2001 FY | -14.32 Million USD | -85.07% |
| 2001 Q2 | -4 Million USD | -53.75% |
| 2001 Q4 | -3.95 Million USD | -5.09% |
| 2000 FY | -7.73 Million USD | -40.94% |
| 2000 Q4 | -2.82 Million USD | -50.0% |
| 2000 Q3 | -1.88 Million USD | -16.09% |
| 2000 Q1 | -1.39 Million USD | 12.04% |
| 2000 Q2 | -1.62 Million USD | -16.13% |
| 1999 FY | -5.49 Million USD | -66.38% |
| 1999 Q4 | -1.59 Million USD | -13.6% |
| 1999 Q2 | -1.2 Million USD | -9.09% |
| 1999 Q1 | -1.1 Million USD | 15.38% |
| 1999 Q3 | -1.4 Million USD | -16.67% |
| 1998 FY | -3.3 Million USD | -153.85% |
| 1998 Q2 | -700 Thousand USD | -16.67% |
| 1998 Q3 | -800 Thousand USD | -14.29% |
| 1998 Q4 | -1.3 Million USD | -62.5% |
| 1998 Q1 | -600 Thousand USD | 0.0% |
| 1997 Q3 | -300 Thousand USD | -250.0% |
| 1997 Q2 | 200 Thousand USD | 0.0% |
| 1997 Q4 | -600 Thousand USD | -100.0% |
| 1997 FY | -1.3 Million USD | -160.0% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1996 FY | -500 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 245.864% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -9582.505% |
| Embecta Corp. | 221.5 Million USD | 209.949% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 377.771% |
| PainReform Ltd. | -9.58 Million USD | -2441.068% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -4989.254% |
| SCYNEXIS, Inc. | 72.66 Million USD | 435.131% |
| Journey Medical Corporation | -2.07 Million USD | -11647.998% |
| Safety Shot Inc | -12.18 Million USD | -1898.793% |
| Alpha Teknova, Inc. | -35.56 Million USD | -584.802% |
| Bright Green Corporation | -8.89 Million USD | -2639.012% |
| Procaps Group, S.A. | 38.97 Million USD | 724.884% |
| Alvotech | -354.86 Million USD | 31.371% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 618.482% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -1512.608% |
| Cosmos Health Inc. | -21.83 Million USD | -1015.54% |
| Dynavax Technologies Corporation | -37.02 Million USD | -557.708% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | -56.551% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | -52.801% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -4989.254% |
| Theratechnologies Inc. | -10.62 Million USD | -2191.672% |
| Harrow Health, Inc. | 580 Thousand USD | 42088.966% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -5080.515% |
| Biofrontera Inc. | -22.67 Million USD | -973.934% |
| DURECT Corporation | -36.88 Million USD | -560.275% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -4522.054% |
| Cronos Group Inc. | -81.37 Million USD | -199.275% |
| OptiNose, Inc. | -22.74 Million USD | -970.582% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 216.504% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | -522.011% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 2027.929% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 2044.399% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -5516.195% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -3821.158% |
| Radius Health, Inc. | -3.92 Million USD | -6104.739% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -6805.347% |
| ProPhase Labs, Inc. | -21.61 Million USD | -1026.803% |
| Phibro Animal Health Corporation | 53.31 Million USD | 556.787% |
| Procaps Group S.A. | 52.32 Million USD | 565.438% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -2757.398% |
| Viatris Inc. | 766.2 Million USD | 131.785% |
| Rockwell Medical, Inc. | -6.67 Million USD | -3551.214% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -4535.249% |
| SIGA Technologies, Inc. | 83.62 Million USD | 391.237% |
| Tilray Brands, Inc. | -174.74 Million USD | -39.367% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 2709.967% |
| Shineco, Inc. | -17.06 Million USD | -1327.035% |
| PetIQ, Inc. | 60.01 Million USD | 505.792% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -5041.442% |
| Incannex Healthcare Limited | -30.04 Million USD | -710.679% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 197.065% |
| Alimera Sciences, Inc. | -1.47 Million USD | -16455.812% |
| Silver Spike Investment Corp. | 7.34 Million USD | 3417.879% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -4033.067% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -1688.422% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -1461.729% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1114.64% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | -76.669% |
| Hempacco Co., Inc. | -8.81 Million USD | -2663.598% |
| Talphera, Inc. | -16.88 Million USD | -1341.98% |
| Alvotech | -354.86 Million USD | 31.371% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 555.599% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 166.788% |
| Currenc Group, Inc. | -6.64 Million USD | -3564.518% |
| Kamada Ltd. | 10.06 Million USD | 2519.873% |
| Indivior PLC | -4 Million USD | -5988.4% |
| Evoke Pharma, Inc. | -7.43 Million USD | -3177.346% |
| Flora Growth Corp. | -50.35 Million USD | -383.648% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1114.64% |
| Evolus, Inc. | -49.23 Million USD | -394.66% |
| HUTCHMED (China) Limited | 18.37 Million USD | 1425.366% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 223.63% |
| Akanda Corp. | -10.05 Million USD | -2322.913% |